Sanofi-aventis to Acquire Genzyme for $74.00 in Cash per Share Plus Contingent Value Right
- Details
- Category: Sanofi
![Sanofi-aventis Sanofi-aventis](/images/stories/logo/sanofi-aventis.gif)
Genzyme Reports Financial Results for Fourth Quarter of 2010 and Full Year
- Details
- Category: Genzyme
![Genzyme Genzyme](/images/stories/logo/genzyme.gif)
Pfēnex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](/images/stories/logo/boehringeringelheim.gif)
Lilly Marks Major Milestone for Mirror Portfolio
- Details
- Category: Eli Lilly and Company
![Eli Lilly Eli Lilly](/images/stories/logo/lilly.gif)
First African country introduces GSK's pneumococcal vaccine
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
New AVERROES Data Demonstrate Investigational Apixaban Superior to Aspirin
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/stories/logo/pfizer_b.gif)
Elan and Boehringer Ingelheim Announce Development and Manufacturing Agreement
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](/images/stories/logo/boehringeringelheim.gif)
More Pharma News ...
- Sanofi-aventis' fourth-quarter and full-year net sales
- Novartis drug Afinitor® extends progression-free survival in patients with advanced pancreatic NET
- FDA Grants Orphan Drug Designation to Regorafenib for the Treatment of Gastrointestinal Stromal Tumors
- Third phase III study of Avastin-based regimen met primary endpoint in ovarian cancer
- GSK revises US Avandia label to include new restrictions on use
- Pfizer To Acquire Ferrosan's Consumer Healthcare Business
- Nycomed to acquire Colombian company Farmacol